00401.HK
Wanjia Group Holdings Limited
HKSE · Healthcare · Medical - Distribution · HK
HKD 0.11
+0.96%Income statement
| Metric | TTM | 2026 | 2025 | 2024 | 2023 |
|---|---|---|---|---|---|
| Revenue | |||||
| Total Revenue | 205.2M | 165.4M | 161.7M | 181.1M | 173.7M |
| Cost of Revenue | 151.5M | 121.0M | 111.3M | 126.4M | 116.8M |
| Gross Profit | 53.8M | 44.4M | 50.3M | 54.7M | 56.9M |
| Operating Expenses | |||||
| R&D Expense | — | — | — | — | — |
| SG&A Expense | 64.0M | 51.7M | 55.8M | 65.5M | 59.4M |
| General & Admin Expense | 14.5M | — | 23.7M | 29.8M | 24.6M |
| Selling & Marketing Expense | 23.3M | — | 32.0M | 35.8M | 34.8M |
| Other Expenses | 283.0K | — | (1.4M) | 28.6M | (6.9M) |
| Total Operating Expenses | 64.2M | 51.7M | 54.4M | 94.2M | 52.5M |
| Cost and Expenses | 215.7M | 172.7M | 165.8M | 220.5M | 168.5M |
| Operating Income (EBIT) | (10.5M) | (7.3M) | (4.1M) | (39.4M) | 4.5M |
| Non-Operating | |||||
| Interest Income | — | 15.0K | 35.0K | 43.0K | 33.0K |
| Interest Expense | 1.0M | 1.0M | 1.4M | 1.7M | 2.0M |
| Net Interest Income | (1.2M) | (1.0M) | (1.4M) | (1.7M) | (2.0M) |
| Other Non-Op Income/Expense | (2.9M) | (1.6M) | (1.4M) | (1.7M) | (2.0M) |
| Non-Operating Income (excl Interest) | (287.5K) | — | — | 24.0M | — |
| EBT (Pre-Tax Income) | (13.4M) | (8.9M) | (5.5M) | (41.1M) | 2.5M |
| Income Tax Expense | 1.1M | 1.1M | 1.1M | (854.0K) | 517.0K |
| Bottom Line | |||||
| Net Income | (14.4M) | (9.9M) | (6.6M) | (40.0M) | 1.8M |
| Earnings from Cont. Ops | (14.6M) | (10.0M) | (6.6M) | (40.3M) | 1.9M |
| Earnings from Discont. Ops | — | — | — | — | — |
| Bottom Line Net Income | (14.4M) | (9.9M) | (6.6M) | (40.0M) | 1.8M |
| Per Share | |||||
| Basic EPS | (HK$0.02) | (HK$0.01) | (HK$0.01) | (HK$0.07) | HK$0.00 |
| Diluted EPS | (HK$0.02) | (HK$0.01) | (HK$0.01) | (HK$0.07) | HK$0.00 |
| Revenue Per Share | HK$0.28 | HK$0.23 | HK$0.29 | HK$0.32 | HK$0.31 |
| Shares | |||||
| Basic Shares Outstanding | 732.2M | 715.8M | 560.2M | 560.2M | 560.2M |
| Diluted Shares Outstanding | 732.2M | 715.8M | 560.2M | 560.2M | 560.2M |
| Profitability Metrics | |||||
| EBITDA | (711.0K) | (711.0K) | 4.1M | (29.0M) | 16.4M |
| D&A | 6.6M | 6.6M | 8.2M | 10.4M | 11.9M |
| EBIT | (10.2M) | (7.3M) | (4.1M) | (39.4M) | 4.5M |
As reported, in the filing currency · TTM sums the four latest quarters; MRQ is the latest quarter · Negatives in parentheses; a dash is a line the filing does not carry · Data as of Mar 1, 2026